Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385695725> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4385695725 endingPage "245.24" @default.
- W4385695725 startingPage "245.24" @default.
- W4385695725 abstract "Abstract Glioblastoma (GBM) is an incurable brain cancer that is associated with severe peripheral immunosuppression. This immunosuppression is a critical barrier to patient survival and the success of immunotherapies. C57BL/6 mice harboring GL261 gliomas present with the hallmark features of peripheral immunosuppression observed in GBM patients, including T cell lymphopenia. We determined that peripheral immunosuppression involves release of non-steroidal soluble factors with large molecular weight that are found in sera of glioma-bearing mice. Sera of glioma-bearing mice inhibits T cell proliferation ex vivo. To determine the identity of the immunosuppressive molecules in serum, we used two parallel approaches: 1.) evaluation of abundant macromolecules and 2.) proteomics analysis using tandem mass tag mass-spectrometry (TMT-MS). We determined that serum of glioma-bearing mice contains significantly higher levels of cell free DNA (cfDNA) compared to controls. TMT-MS identified histones as a highly abundant protein in serum, further implicating DNA-histone complexes as top candidates. DNAse treatment of sera isolated from GL261 glioma-bearing mice reduced the suppressive effect on T cell proliferation. We next performed T cell proliferation assays in the presence of pure cfDNA isolated from sera of glioma-bearing mice while genomic DNA was used as control. cfDNA from serum potently inhibited T cell proliferation while control genomic DNA did not. These results were AIM2 independent implicating a novel pathway of DNA sensing in T cells. We contend that cfDNA induces immunosuppressive effects in experimental GBM. Devising strategies to reverse immunosuppression through targeting cfDNA could improve outcomes in GBM patients. Supported by grants from NIH (K99NS117799-01A1 (KA), R01NS103212 (AJJ), and RF1NS122174(AJJ) and Brains Together for a Cure Foundation (KA)." @default.
- W4385695725 created "2023-08-10" @default.
- W4385695725 creator A5009735508 @default.
- W4385695725 creator A5010436042 @default.
- W4385695725 creator A5024074311 @default.
- W4385695725 creator A5027148503 @default.
- W4385695725 creator A5032538191 @default.
- W4385695725 creator A5044577075 @default.
- W4385695725 creator A5069162526 @default.
- W4385695725 creator A5078328892 @default.
- W4385695725 creator A5084816491 @default.
- W4385695725 creator A5084993777 @default.
- W4385695725 creator A5092011204 @default.
- W4385695725 date "2023-05-01" @default.
- W4385695725 modified "2023-10-16" @default.
- W4385695725 title "Circulating cell-free DNA directly inhibits T cell function and contributes to peripheral immunosuppression in experimental GBM" @default.
- W4385695725 doi "https://doi.org/10.4049/jimmunol.210.supp.245.24" @default.
- W4385695725 hasPublicationYear "2023" @default.
- W4385695725 type Work @default.
- W4385695725 citedByCount "0" @default.
- W4385695725 crossrefType "journal-article" @default.
- W4385695725 hasAuthorship W4385695725A5009735508 @default.
- W4385695725 hasAuthorship W4385695725A5010436042 @default.
- W4385695725 hasAuthorship W4385695725A5024074311 @default.
- W4385695725 hasAuthorship W4385695725A5027148503 @default.
- W4385695725 hasAuthorship W4385695725A5032538191 @default.
- W4385695725 hasAuthorship W4385695725A5044577075 @default.
- W4385695725 hasAuthorship W4385695725A5069162526 @default.
- W4385695725 hasAuthorship W4385695725A5078328892 @default.
- W4385695725 hasAuthorship W4385695725A5084816491 @default.
- W4385695725 hasAuthorship W4385695725A5084993777 @default.
- W4385695725 hasAuthorship W4385695725A5092011204 @default.
- W4385695725 hasBestOaLocation W43856957251 @default.
- W4385695725 hasConcept C1491633281 @default.
- W4385695725 hasConcept C153911025 @default.
- W4385695725 hasConcept C203014093 @default.
- W4385695725 hasConcept C2776090121 @default.
- W4385695725 hasConcept C2778227246 @default.
- W4385695725 hasConcept C2780252810 @default.
- W4385695725 hasConcept C502942594 @default.
- W4385695725 hasConcept C54355233 @default.
- W4385695725 hasConcept C62112901 @default.
- W4385695725 hasConcept C86803240 @default.
- W4385695725 hasConcept C8891405 @default.
- W4385695725 hasConceptScore W4385695725C1491633281 @default.
- W4385695725 hasConceptScore W4385695725C153911025 @default.
- W4385695725 hasConceptScore W4385695725C203014093 @default.
- W4385695725 hasConceptScore W4385695725C2776090121 @default.
- W4385695725 hasConceptScore W4385695725C2778227246 @default.
- W4385695725 hasConceptScore W4385695725C2780252810 @default.
- W4385695725 hasConceptScore W4385695725C502942594 @default.
- W4385695725 hasConceptScore W4385695725C54355233 @default.
- W4385695725 hasConceptScore W4385695725C62112901 @default.
- W4385695725 hasConceptScore W4385695725C86803240 @default.
- W4385695725 hasConceptScore W4385695725C8891405 @default.
- W4385695725 hasIssue "1_Supplement" @default.
- W4385695725 hasLocation W43856957251 @default.
- W4385695725 hasOpenAccess W4385695725 @default.
- W4385695725 hasPrimaryLocation W43856957251 @default.
- W4385695725 hasRelatedWork W2032981778 @default.
- W4385695725 hasRelatedWork W2523765634 @default.
- W4385695725 hasRelatedWork W2580761780 @default.
- W4385695725 hasRelatedWork W2605096019 @default.
- W4385695725 hasRelatedWork W2753438087 @default.
- W4385695725 hasRelatedWork W2762525387 @default.
- W4385695725 hasRelatedWork W2995726900 @default.
- W4385695725 hasRelatedWork W3005634848 @default.
- W4385695725 hasRelatedWork W3015696786 @default.
- W4385695725 hasRelatedWork W3092796849 @default.
- W4385695725 hasVolume "210" @default.
- W4385695725 isParatext "false" @default.
- W4385695725 isRetracted "false" @default.
- W4385695725 workType "article" @default.